WO2001034840A3 - Genetic compositions and methods - Google Patents

Genetic compositions and methods Download PDF

Info

Publication number
WO2001034840A3
WO2001034840A3 PCT/US2000/030766 US0030766W WO0134840A3 WO 2001034840 A3 WO2001034840 A3 WO 2001034840A3 US 0030766 W US0030766 W US 0030766W WO 0134840 A3 WO0134840 A3 WO 0134840A3
Authority
WO
WIPO (PCT)
Prior art keywords
sites
nucleic acid
phenotypic traits
methods
probes
Prior art date
Application number
PCT/US2000/030766
Other languages
French (fr)
Other versions
WO2001034840A2 (en
Inventor
Karin Au
Jingwen Chen
Nila Patil
Daryl Thomas
Original Assignee
Glaxo Group Ltd
Affymetrix Inc
Karin Au
Jingwen Chen
Nila Patil
Daryl Thomas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Affymetrix Inc, Karin Au, Jingwen Chen, Nila Patil, Daryl Thomas filed Critical Glaxo Group Ltd
Priority to AU14776/01A priority Critical patent/AU1477601A/en
Publication of WO2001034840A2 publication Critical patent/WO2001034840A2/en
Publication of WO2001034840A3 publication Critical patent/WO2001034840A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention provides nucleic acid segments derived from the human genome, including polymorphic sites. Allele-specific primers and probes hybridizing to these sites and to regions flanking these sites are also provided. This invention further provides methods of analyzing a nucleic acid from an individual or a group of individuals. The nucleic acids, primers, and probes are useful tools for applications including forensics, paternity testing, medicine, e.g., the corelation of polymorphisms with phenotypic traits, and genetic analysis, e.g., genetic mapping of such phenotypic traits.
PCT/US2000/030766 1999-11-10 2000-11-10 Genetic compositions and methods WO2001034840A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU14776/01A AU1477601A (en) 1999-11-10 2000-11-10 Genetic compositions and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16459699P 1999-11-10 1999-11-10
US60/164,596 1999-11-10

Publications (2)

Publication Number Publication Date
WO2001034840A2 WO2001034840A2 (en) 2001-05-17
WO2001034840A3 true WO2001034840A3 (en) 2002-01-24

Family

ID=22595202

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030766 WO2001034840A2 (en) 1999-11-10 2000-11-10 Genetic compositions and methods

Country Status (2)

Country Link
AU (1) AU1477601A (en)
WO (1) WO2001034840A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206478B2 (en) 2002-12-31 2015-12-08 Branhaven LLC Methods and systems for inferring bovine traits

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129642D0 (en) * 2001-12-11 2002-01-30 King S College London Detection of disease dve to oestrogen deficiency
US8067171B2 (en) * 2008-04-18 2011-11-29 Wisconsin Alumni Research Foundation Methods and compositions for improved fertilization and embryonic survial
CN102533774A (en) * 2011-12-19 2012-07-04 西北农林科技大学 Single nucleotide polymorphism sequence of dairy cattle FGF2 (Fibroblast Growth Factor 2) gene and detection method of single nucleotide polymorphism sequence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012607A1 (en) * 1993-11-03 1995-05-11 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
WO1999053095A2 (en) * 1998-04-09 1999-10-21 Whitehead Institute For Biomedical Research Biallelic markers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012607A1 (en) * 1993-11-03 1995-05-11 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
WO1999053095A2 (en) * 1998-04-09 1999-10-21 Whitehead Institute For Biomedical Research Biallelic markers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WANG D ET AL: "Toward a third generation genetic map of the human genome based in bi-allelic polymorphisms.", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 59, no. 4 SUPPL., 1996, 46th Annual Meeting of the American Society of Human Genetics;San Francisco, California, USA; October 29-November 2, 1996, pages A3, XP002050641, ISSN: 0002-9297 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206478B2 (en) 2002-12-31 2015-12-08 Branhaven LLC Methods and systems for inferring bovine traits

Also Published As

Publication number Publication date
AU1477601A (en) 2001-06-06
WO2001034840A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
WO1998020165A3 (en) Biallelic markers
CA2289872A1 (en) Target-dependent reactions using structure-bridging oligonucleotides
WO1999014375A3 (en) Dna typing by mass spectrometry with polymorphic dna repeat markers
WO2004023092A3 (en) Genetic analysis and authentication
WO2001013086A3 (en) Detection of nucleic acids
CA2209991A1 (en) Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia
IL145141A0 (en) Compositions and methods for genetic analysis
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO2001066800A8 (en) Human single nucleotide polymorphisms
WO2002081742A3 (en) Method for the detection of cytochrome b mutations in fungi
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
ATE427362T1 (en) POLYMORPHOIC MARKERS OF THE LSR GENE
EP1947104A3 (en) Method and compositions for identifying and characterizing hepatitis C
WO1993018178A1 (en) DIAGNOSIS OF β-THALASSEMIA USING A MULTIPLEX AMPLIFICATION REFRACTORY MUTATION SYSTEM
AU4766000A (en) Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
WO2001034840A3 (en) Genetic compositions and methods
EP1262565A3 (en) Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
WO2005024068A3 (en) Allele-specific sequence variation analysis
WO2001042511A3 (en) Ibd-related polymorphisms
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
WO2001038576A3 (en) Human single nucleotide polymorphisms
WO2003031641A3 (en) Beta 2 adrenergic polymorphism detection
WO1999053095A3 (en) Biallelic markers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase